Prognostic Stratification of Stage IIIA-N2 Non–Small-Cell Lung Cancer After Induction Chemotherapy: A Model Based on the Combination of Morphometric-Pathologic Response in Mediastinal Nodes and Primary Tumor Response on Serial 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography

This publication has 26 references indexed in Scilit:

• Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study
  British Journal of Cancer, 2006
• Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy
  European Journal of Cardio-Thoracic Surgery, 2005
• Surgical Resection for Residual N2 Disease After Induction Chemotherapy
  The Annals of Thoracic Surgery, 2005
• Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
  Annals of Oncology, 2004
• The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer
  Lung Cancer, 2003
• Long-Term Results of Combined-Modality Therapy in Resectable Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2002
• Grading of Tumor Regression in Non-small Cell Lung Cancer
  Chest, 2001
• Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival
  The Annals of Thoracic Surgery, 2000
• Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and Implications
  Journal of Clinical Oncology, 2000
• Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.
  Journal of Clinical Oncology, 1998